Cancer trial challenges standard practice: keep using drug after it stops working?
Disease control
Recruiting now
This large Phase 3 trial is testing whether continuing the targeted drug cetuximab after initial treatment stops working can help control metastatic colorectal cancer. The study will compare continuing cetuximab with switching to a different drug (bevacizumab), both given with ch…
Phase: PHASE3 • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC